- Age of Onset in Schizophrenia Spectrum Disorders: Complex Interactions between Genetic and Environmental Factors
-
Mandelli L, Toscano E, Porcelli S, Fabbri C, Serretti A
- KMID: 2316623
- Psychiatry Investig.
- 2016 Mar;13(2):247-249.
- doi: 10.4306/pi.2016.13.2.247
In this study we evaluated the role of a candidate gene for major psychosis, Sialyltransferase (ST8SIA2), in the risk to develop a schizophrenia spectrum disorders, taking into account exposure to... -
- CITED
-
- Close
- SHARE
-
- Close
- Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial
-
Han Cs, Wang SM, Bahk WM, Lee SJ, Patkar AA, Masand PS, Mandelli L, Pae CU, Serretti A
- KMID: 2508991
- Clin Psychopharmacol Neurosci.
- 2020 Nov;18(4):641.
- doi: 10.9758/cpn.2020.18.4.641
-
- CITED
-
- Close
- SHARE
-
- Close
- Effect of the Dysbindin Gene on Antimanic Agents in Patients with Bipolar I Disorder
-
Yun DH, Pae CU, Drago A, Mandelli L, De Ronchi , Patkar AA, Paik IH, Serretti A, Kim JJ
- KMID: 1706123
- Psychiatry Investig.
- 2008 Jun;5(2):102-105.
- doi: 10.4306/pi.2008.5.2.102
OBJECTIVE: We previously reported an association between dysbindin gene (DTNBP1) variants and bipolar I disorder (BID). This paper expands upon previous findings suggesting that DTNBP1 variants may play a role... -
- CITED
-
- Close
- SHARE
-
- Close
- Possible Modulatory Role of ARC Gene Variants in Mood Disorders
-
Crisafulli C, Calabrò M, Mandelli L, Wang SM, Lee SJ, Han C, Patkar A, Masand P, Pae CU, Souery D, Mendlewicz J, Serretti A
- KMID: 2513389
- Clin Psychopharmacol Neurosci.
- 2021 Feb;19(1):46-52.
- doi: 10.9758/cpn.2021.19.1.46
Objective: The genetic background of mood disorders is gradually emerging through the use of large multicenter samples but a detailed phenotyping is complementary in elucidating the role of modulating variants. Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- ZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders
-
Calabrò M, Mandelli L, Crisafulli C, Nicola MD, Colombo R, Janiri L, Lee SJ, Jun TY, Wang SM, Masand PS, Patkar AA, Han C, Pae CU, Serretti A
- KMID: 2502148
- Clin Psychopharmacol Neurosci.
- 2020 May;18(2):231-240.
- doi: 10.9758/cpn.2020.18.2.231
Objective: Genetic variations in the gene encoding zinc finger protein 804A gene (ZNF804A) have been associated with major depression and bipolar disorder. In this work we focused on the potential... -
- CITED
-
- Close
- SHARE
-
- Close
- Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for CACNA1C, CHRNA7 and MAPK1
-
Calabrò M, Mandelli L, Crisafulli C, Lee SJ, Jun TY, Wang SM, Patkar AA, Masand PS, Han C, Pae CU, Serretti A
- KMID: 2457399
- Clin Psychopharmacol Neurosci.
- 2019 Aug;17(3):364-368.
- doi: 10.9758/cpn.2019.17.3.364
OBJECTIVE: Genetics factors are likely to play a role in the risk, clinical presentation and treatment outcome in major depressive disorder (MDD). In this study, we investigated the role of... -
- CITED
-
- Close
- SHARE
-
- Close
- A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial
-
Han C, Wang SM, Bahk WM, Lee SJ, Patkar AA, Masand PS, Mandelli L, Pae CU, Serretti A
- KMID: 2428976
- Clin Psychopharmacol Neurosci.
- 2018 Nov;16(4):469-480.
- doi: 10.9758/cpn.2018.16.4.469
OBJECTIVE: Pharmacogenomic-based antidepressant treatment (PGATx) may result in more precise pharmacotherapy of major depressive disorder (MDD) with better drug therapy guidance. METHODS: An 8-week, randomized, single-blind clinical trial was conducted to... -
- CITED
-
- Close
- SHARE
-
- Close
